Abstract

The COVID-19 pandemic has affected the mental health of people around the world. However, its impact on first-episode psychosis (FEP) remains unclear. The aim of this study was to determine the incidence rate (IR) and the clinical and sociodemographic characteristics of patients who developed FEP during the nine-month period following the COVID-19 outbreak in Spain and to compare these data to the corresponding period in the previous year. We included all patients (n = 220) treated for the first time during these two time periods at three FEP programs in Spain. The IR was 0.42/100,000 person-years during the pandemic vs. 0.54/100,000 in the prior year (p = 0.057). Compared to prior year, women accounted for a significantly higher proportion of FEP patients (46.3% vs. 28%; p = 0.005) during the COVID-19 period. This association was significant on the logistic regression analysis (odds ratio, female: 2.12 [confidence interval 1.17–3.82]; p = 0.014). These data reveal a non-significant trend towards a lower incidence of FEP during the pandemic period. Female sex was associated with a greater risk of developing FEP during the pandemic period, perhaps due to differences between males and females in the susceptibility and expression of psychosis. The findings of this study contribute to a better understanding of stress-related disorders.

Details

Title
Incidence rate and distinctive characteristics of first episode psychosis during the COVID-19 pandemic: a multicenter observational study
Author
Casanovas, Francesc 1 ; Trabsa, Amira 2 ; Bergé, Daniel 3 ; Sánchez-Gistau, Vanessa 4 ; Moreno, Irene 4 ; Sanchez, Julia 4 ; Montalvo, Itziar 5 ; Tost, Meritxell 5 ; Labad, Javier 6 ; Pérez-Solà, Victor 3 ; Mané, Anna 3   VIAFID ORCID Logo 

 Institut de Neuropsiquiatria i Adiccions (INAD), Parc de Salut Mar, Barcelona, Spain (GRID:grid.418476.8) (ISNI:0000 0004 1767 8715) 
 Institut de Neuropsiquiatria i Adiccions (INAD), Parc de Salut Mar, Barcelona, Spain (GRID:grid.418476.8) (ISNI:0000 0004 1767 8715); Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain (GRID:grid.20522.37) (ISNI:0000 0004 1767 9005) 
 Institut de Neuropsiquiatria i Adiccions (INAD), Parc de Salut Mar, Barcelona, Spain (GRID:grid.418476.8) (ISNI:0000 0004 1767 8715); Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain (GRID:grid.20522.37) (ISNI:0000 0004 1767 9005); Universitat Pompeu Fabra, Department of Medicine and Life Sciences (MELIS), Barcelona, Spain (GRID:grid.5612.0) (ISNI:0000 0001 2172 2676); Área de Salud Mental (CIBERSAM), Centro de Investigación Biomédica en Red, Madrid, Spain (GRID:grid.469673.9) (ISNI:0000 0004 5901 7501) 
 Área de Salud Mental (CIBERSAM), Centro de Investigación Biomédica en Red, Madrid, Spain (GRID:grid.469673.9) (ISNI:0000 0004 5901 7501); Hospital Universitari Institut Pere Mata, IISPV, Universitat Rovira i Virgili, Reus, Spain (GRID:grid.410367.7) (ISNI:0000 0001 2284 9230) 
 Área de Salud Mental (CIBERSAM), Centro de Investigación Biomédica en Red, Madrid, Spain (GRID:grid.469673.9) (ISNI:0000 0004 5901 7501); Hospital Universitari Parc Taulí, I3PT, Department of Mental Health, Sabadell, Spain (GRID:grid.488873.8) (ISNI:0000 0004 6346 3600) 
 Área de Salud Mental (CIBERSAM), Centro de Investigación Biomédica en Red, Madrid, Spain (GRID:grid.469673.9) (ISNI:0000 0004 5901 7501); Hospital Universitari Parc Taulí, I3PT, Department of Mental Health, Sabadell, Spain (GRID:grid.488873.8) (ISNI:0000 0004 6346 3600); Consorci Sanitari del Maresme, Department of Mental Health, Mataró, Spain (GRID:grid.466613.0) (ISNI:0000 0004 1770 3861) 
Pages
22036
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2756517092
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.